MedTrace Logo

MDR - M/L Taper With Kinectiv Technology Stems and Necks

NCT04027140 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-12-31

No results posted yet for this study

Summary

The objective of this consecutive series PMCF study is to collect data confirming safety, performance and clinical benefits of the M/L Taper with Kinectiv Technology Stems and Necks when used for primary or revision total hip arthroplasty (implants) at 1,2,5 and 10-year follow-up\*. ML Taper with Kinectiv Technology has been on the market since 2008, but has insufficient long term clinical data. Therefore, a prospective aspect to the study will be necessary to reach the 10-year time point.

Conditions

  • Hip Disease
  • Hip Fractures
  • Hip Injuries
  • Hip Arthritis
  • Hip Pain Chronic

Interventions

DEVICE

M/L Taper with Kinectiv Technology Stems and Necks

Patients that have been implanted with a M/L Taper with Kinectiv Technology Stem and/or neck to repair hip malfunction/disease.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Lynsey Boyle · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-22
Primary Completion
2024-11-05
Completion
2024-11-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027140 on ClinicalTrials.gov